Case Study: Risk-Calibrated RBQM, CTMS/IWRS & Alzheimer Ops
Five pragmatic lessons from 2024–2025 trials: risk-calibrated RBQM, CTMS/IWRS site activation, targeted obesity recruitment, decentralized Alzheimer biomarker operations, and caregiver-centered tactics.
Robert Maxwell
Oct 30, 2025
breast cancer trials
obesity intervention studies
Alzheimer disease biomarkers
Influenza vaccine studies